Madina Agénor1, Sarah M Peitzmeier2, Allegra R Gordon3,4, Brittany M Charlton3,4, Sebastien Haneuse5, Jennifer Potter6,7,8, S Bryn Austin9,3,4. 1. Department of Social and Behavioral Sciences, Harvard T.H. Chan School of Public Health, 677 Huntington Avenue, Kresge Building, 7th Floor, Boston, MA, 02115, USA. magenor@mail.harvard.edu. 2. Department of Population, Family and Reproductive Health, Johns Hopkins School of Public Health, Baltimore, MD, USA. 3. Division of Adolescent and Young Adult Medicine, Boston Children's Hospital, Boston, MA, USA. 4. Department of Pediatrics, Harvard Medical School, Boston, MA, USA. 5. Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA. 6. Department of Medicine, Harvard Medical School, Boston, MA, USA. 7. Division of General Medicine and Primary Care, Beth Israel Deaconess Medical Center, Boston, MA, USA. 8. The Fenway Institute, Fenway Health, Boston, MA, USA. 9. Department of Social and Behavioral Sciences, Harvard T.H. Chan School of Public Health, 677 Huntington Avenue, Kresge Building, 7th Floor, Boston, MA, 02115, USA.
Abstract
PURPOSE: To examine the association between sexual orientation identity and human papillomavirus (HPV) vaccination initiation and completion among both women and men. METHODS: Using data from the 2013 and 2014 National Health Interview Survey, we estimated logistic regression models for the association between sexual orientation identity and HPV vaccination initiation (≥1 dose) and completion (≥3 doses) among US women and men in relation to sociodemographic and healthcare factors. Analyses were restricted to individuals for whom the HPV vaccine was recommended at some point in their lives, namely women aged 18-34 years (n = 9,734) and men aged 18-31 years (n = 6,812). RESULTS: Among all women, bisexual women had higher adjusted odds of HPV vaccination initiation [(odds ratio) 1.71; (95 % confidence interval) 1.20-2.45] and completion (1.59; 1.05-2.42) than heterosexual women. No difference was observed in the odds of HPV vaccination initiation or completion between lesbian and heterosexual women. Among women who had initiated HPV vaccination, lesbians had lower adjusted odds of completion than heterosexual women (0.41; 0.19-0.90). Among all men, gay men had higher adjusted odds of initiating (2.07; 1.17-3.52) and completing (3.90; 1.68-9.06) HPV vaccination than heterosexual men. No difference was observed in the odds of HPV vaccination initiation or completion between bisexual and heterosexual men. Among men who had initiated HPV vaccination, gay (4.36; 1.28-14.83) and bisexual (20.92; 2.34-186.73) men had higher adjusted odds of completion than heterosexual men, although these results are unreliable and should be interpreted with caution. CONCLUSIONS: Interventions are needed to promote HPV vaccination among all US women and men, regardless of sexual orientation identity.
PURPOSE: To examine the association between sexual orientation identity and human papillomavirus (HPV) vaccination initiation and completion among both women and men. METHODS: Using data from the 2013 and 2014 National Health Interview Survey, we estimated logistic regression models for the association between sexual orientation identity and HPV vaccination initiation (≥1 dose) and completion (≥3 doses) among US women and men in relation to sociodemographic and healthcare factors. Analyses were restricted to individuals for whom the HPV vaccine was recommended at some point in their lives, namely women aged 18-34 years (n = 9,734) and men aged 18-31 years (n = 6,812). RESULTS: Among all women, bisexual women had higher adjusted odds of HPV vaccination initiation [(odds ratio) 1.71; (95 % confidence interval) 1.20-2.45] and completion (1.59; 1.05-2.42) than heterosexual women. No difference was observed in the odds of HPV vaccination initiation or completion between lesbian and heterosexual women. Among women who had initiated HPV vaccination, lesbians had lower adjusted odds of completion than heterosexual women (0.41; 0.19-0.90). Among all men, gay men had higher adjusted odds of initiating (2.07; 1.17-3.52) and completing (3.90; 1.68-9.06) HPV vaccination than heterosexual men. No difference was observed in the odds of HPV vaccination initiation or completion between bisexual and heterosexual men. Among men who had initiated HPV vaccination, gay (4.36; 1.28-14.83) and bisexual (20.92; 2.34-186.73) men had higher adjusted odds of completion than heterosexual men, although these results are unreliable and should be interpreted with caution. CONCLUSIONS: Interventions are needed to promote HPV vaccination among all US women and men, regardless of sexual orientation identity.
Entities:
Keywords:
Gender; Health disparities; Human papillomavirus vaccination; Sexual orientation; Young adults
Authors: Brittany M Charlton; Heather L Corliss; Stacey A Missmer; A Lindsay Frazier; Margaret Rosario; Jessica A Kahn; S Bryn Austin Journal: J Adolesc Health Date: 2011-06-08 Impact factor: 5.012
Authors: Heather L McCauley; Jay G Silverman; Michele R Decker; Madina Agénor; Sonya Borrero; Daniel J Tancredi; Sarah Zelazny; Elizabeth Miller Journal: J Womens Health (Larchmt) Date: 2015-05-11 Impact factor: 2.681
Authors: Madina Agénor; Sarah Peitzmeier; Allegra R Gordon; Sebastien Haneuse; Jennifer E Potter; S Bryn Austin Journal: Ann Intern Med Date: 2015-07-21 Impact factor: 25.391
Authors: Susan Hariri; Elizabeth R Unger; Maya Sternberg; Eileen F Dunne; David Swan; Sonya Patel; Lauri E Markowitz Journal: J Infect Dis Date: 2011-08-15 Impact factor: 5.226
Authors: Sarah Reagan-Steiner; David Yankey; Jenny Jeyarajah; Laurie D Elam-Evans; James A Singleton; C Robinette Curtis; Jessica MacNeil; Lauri E Markowitz; Shannon Stokley Journal: MMWR Morb Mortal Wkly Rep Date: 2015-07-31 Impact factor: 17.586
Authors: Madina Agénor; Ashley E Pérez; Sarah M Peitzmeier; Jennifer Potter; Sonya Borrero Journal: J Womens Health (Larchmt) Date: 2018-06-29 Impact factor: 2.681
Authors: Madina Agénor; Gabriel R Murchison; Jarvis T Chen; Deborah J Bowen; Meredith B Rosenthal; Sebastien Haneuse; Sydney Bryn Austin Journal: Health Serv Res Date: 2019-11-10 Impact factor: 3.402
Authors: Paul L Reiter; Mira L Katz; José A Bauermeister; Abigail B Shoben; Electra D Paskett; Annie-Laurie McRee Journal: LGBT Health Date: 2018-07 Impact factor: 4.151
Authors: Brittany M Charlton; Sari L Reisner; Madina Agénor; Allegra R Gordon; Vishnudas Sarda; S Bryn Austin Journal: LGBT Health Date: 2017-05-03 Impact factor: 4.151
Authors: Alan G Nyitray; Kayo Fujimoto; Jing Zhao; Anna R Giuliano; John A Schneider; Lu-Yu Hwang Journal: J Infect Dis Date: 2018-02-14 Impact factor: 5.226